Children with the skin condition atopic dermatitis (AD, or eczema) who are vaccinated against COVID-19 may experience fewer related infections and allergic complications, according to new research presented at the recent American College of Allergy, Asthma and Immunology Annual Scientific Meeting in Florida.
University of Texas researchers analyzed data from 5,758 vaccinated and the same number of unvaccinated AD patients younger than 17 years matched for demographics and health history to determine if COVID-19 vaccination reduces AD-related infections and complications.
"Atopic dermatitis is a chronic skin condition driven by the immune system and often precedes the development of asthma and allergic rhinitis," first author Tristan Nguyen, a medical student, said in the news release. "Children with AD are also at higher risk for infections, including those affecting the skin and respiratory system."
Onset of several conditions delayed after immunization
Relative to unvaccinated children, those who were vaccinated had significantly fewer infections such as ear infections, pneumonia, bronchitis, bronchiolitis, sinusitis, and upper respiratory infections.